MedPath

Rhythm and Depression

Not Applicable
Conditions
Depression
Interventions
Other: rhythmic parameter recording
Behavioral: psychiatric assessment
Registration Number
NCT02857036
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The study aims to characterize the rhythmic parameters of unipolar depressed patients that are associated with the response to antidepressants after 6 weeks of treatment.

Detailed Description

Patients are included at the time of their hospitalization in the psychiatry unit. They perform rhythmic parameters recording within 48hours after the initiation of the antidepressant treatment. An evaluation of the evaluation of the severity of depression symptoms is performed at 2, 4 and 6 weeks after the initiation of the antidepressant treatment.

A correlation analysis will be performed with rhythmic parameters and the response to the antidepressant treatment.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • current unipolar major depressive disorder according to the Diagnostic ans Statistics Manual (DSM)V
  • MADRS score > 25
Exclusion Criteria
  • other psychiatric disorder
  • current treatment with thymoregulating agent
  • clozapine treatment
  • heart disease that could alter heart rate characteristics
  • disease associated with fever
  • shift work within 3 months before inclusion
  • transmeridian travel in the preceding month
  • guardianship

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
responderrhythmic parameter recordingresponder to antidepressant treatment
non responderrhythmic parameter recordingnon responder to antidepressant treatment
non responderpsychiatric assessmentnon responder to antidepressant treatment
responderpsychiatric assessmentresponder to antidepressant treatment
Primary Outcome Measures
NameTimeMethod
significant difference of temperature amplitude between responder and non-responder6 weeks

the response to the antidepressant treatment is determined by the variation of the MADRS score between pretreatment and 6 weeks of treatment.

the complete response is obtained when the MADRS score has at least a 50% decrease after 6 weeks.

significant difference of activity duration between responder and non-responder6 weeks
significant difference of RR interval of the heart rate between responder and non-responder6 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Besancon

🇫🇷

Besancon, Doubs, France

© Copyright 2025. All Rights Reserved by MedPath